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Abstract Melittin, the 26-residue predominant toxic peptide
from bee venom, exhibits potent antibacterial activity in addition
to its hemolytic activity. The synthetic peptide of 15 residues
corresponding to its C-terminal end (MCF), which encompasses
its most amphiphilic segment, is now being shown to possess
antibacterial activity about 5^7 times less compared to that of
melittin. MCF, however, is 300 times less hemolytic. An analog
of MCF, MCFA, in which two cationic residues have been trans-
positioned to the N-terminal region from the C-terminal region,
exhibits antibacterial activity comparable to that of melittin, but
is only marginally more hemolytic than MCF. The biophysical
properties of the peptides, like folding and aggregation, correlate
well with their biological properties.
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1. Introduction
The emergence of microbes that are resistant to convention-
ally used antibiotics has triggered considerable interest in the
structure-function relationship studies in short antimicrobial
peptides in recent years [1]. In addition to naturally occurring
short antimicrobial peptides like indolicidin, protegrins and
tachyplesins, shorter segments of comparatively larger pepti-
des and proteins like seminalplasmin, cecropins, neuropeptide
Y, dermaseptins and lactoferrin have been studied in consid-
erable detail [2^12]. These studies are aimed at not only delin-
eating the structural requirements for selective antimicrobial
activity but also to develop peptides that could have potential
as therapeutic agents. As cationic antimicrobial peptides are a
part of innate immunity in a wide variety of organisms across
the evolutionary scale and are known to rapidly kill micro-
organisms by permeabilizing their membranes, a mechanism
di¡erent from other antibiotics, resistance is not likely to de-
velop to them easily [1,13^15].
Melittin, a 26-residue peptide, present as the major toxic
component of the European bee venom, Apis mellifera is char-
acterized by its powerful hemolytic activity [16]. Although it
possesses potent antimicrobial activity its overriding cytotoxic
e¡ect makes it unsuitable for any therapeutic use. Several
reports have appeared describing non-hemolytic analogs of
melittin that retain their antimicrobial activity. These analogs
include retro, retro-enantio and dia-stereo analogs and all of
them are of the same length as melittin [16,17]. In this paper
we describe the synthesis and biological activity of the C-ter-
minal 15-residue fragment of melittin as well as an analog of
this peptide with antimicrobial activity comparable to that of
melittin, but with much reduced hemolytic activity.
2. Materials and methods
2.1. Peptides
Melittin was purchased from Sigma (St. Louis, MO, USA). MCF
and MCFA (Fig. 1) were synthesized by manual methods using £uo-
renylmethoxycarbonyl (Fmoc) chemistry on PAL resin (Advanced
Chem Tech, Louisville, KY, USA) [18,19]. All amino acids were
added as Fmoc amino acids with coupling mediated by 2(1H-ben-
zotriazol-1-yl)-1,1,3,3-tetramethyluroniumhexa£uorophosphate/1-oxy-
benzo-triazole (HBTU/HOBT). The synthesis was performed on 0.05
mmol scale using V125 mg of resin. Cleavage of the peptide from the
resin was e¡ected by acidolysis using tri£uoroacetic acid, thioanisole,
metacresol and ethanedithiol (10:1:1:0.5). Peptides were checked for
purity on HPLC using a Biorad C4 column. Puri¢ed peptides were
characterized by liquid secondary ion mass spectrometry, on a VG
Autospec-M Mass spectrometer and amino acid analysis on a Phar-
macia LKB 4151 Alpha Plus amino acid analyzer.
2.2. Antimicrobial activity
The antimicrobial activity of the peptides was assayed in nutrient
broth (6 g of bactonutrient broth and 5 g of NaCl per liter medium)
under aerobic conditions. Di¡erent concentrations of peptides were
added to 1 ml medium containing the inocula of the test organism
(V106 CFU) in mid-logarithmic phase of growth. Microbial growth
was assessed by recording the increase in OD600, after incubating at
37‡C or 30‡C for 6^9 h. The lowest concentration that resulted in
complete inhibition of growth was taken as minimal inhibitory con-
centration (MIC). The microorganisms used were E. coli, S. aureus, P.
putida and B. subtilis.
Inner membrane permeability of E. coli W 160-37 was monitored
by measuring the L-galactosidase activity in the cells (in which the
enzyme has been previously induced with 5U1034 M IPTG), in the
presence of di¡erent concentrations of the peptides. Ortho-nitrophenyl
galactoside (ONPG) was used as the substrate. Cells incubated in the
absence of the peptides served as the control. OD measurements were
made at 550 and 420 nm and (A42031.75UA550) was taken as a
measure of L-galactosidase activity [6].
2.3. Hemolytic activity
The hemolytic activities of the peptides were evaluated with rat
erythrocytes. Erythrocytes were isolated from heparinized blood by
centrifugation and washed thrice with phosphate bu¡ered saline
(PBS). Aliquots of 1 ml suspension containing 107 cells in Eppendorf
tubes were incubated at 37‡C in duplicates for 30 min with gentle
mixing. The tubes were then centrifuged and the absorbance of the
supernatants was measured at 540 nm. The lysis obtained with water
was considered 100%. Osmotic protection experiments were done by
including 30 mM of one of the osmoticants, D-mannitol, sucrose,
ra⁄nose or PEGs of molecular weights 600 or 1000 in the hemolytic
assay.
2.4. Circular dichroism (CD) studies
CD spectra were recorded using a JASCO-J-715 spectro polarimeter
under nitrogen £ush in 0.1 cm path length cells at 25‡C. Spectra were
recorded between 250^200 nm and average of three recordings was
taken. Calibration was carried out with d-camphorsulfonic acid. Data
are represented as mean residue ellipticities. Fractional helicities were
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calculated by using the formula fh  a2223a0222=a100222, where [a]222
is the experimentally observed ellipticity at 222 nm. Values of 328 400
and 32000 were taken for 100% (a100222] and 0% [a0222) helix content
respectively [20].
2.5. Light scattering
Aggregation of melittin, MCF, and MCFA as a function of con-
centration in aqueous solutions was monitored by 90‡ angle scattering
on a spectro£ourimeter by ¢xing both excitation and emission mono-
chromators at 600 nm.
2.6. Fluorescence spectroscopy
All steady state £uorescence spectra and scattering were recorded
on a Hitachi 650-10S spectro£uorimeter at 25‡C. Emission spectra of
the peptides were recorded between 320 and 400 nm with the excita-
tion monochromator set at 280 nm.
3. Results
The sequences of melittin, C-terminal 15-residue synthetic
fragment of melittin, MCF, and its analog MCFA are shown
in Fig. 1. Additional glycine amide was introduced at the C-
terminal end of both MCF and MCFA for synthetic conven-
ience. Helical wheel diagrams of MCF and MCFA along with
their mean hydrophobicity (6Hs ) and hydrophobic mo-
ments (6WHs ) are presented in Fig. 1.
Melittin has earlier been shown to possess antibacterial ac-
tivity and hence the antimicrobial activity of the three pepti-
des melittin, MCF and MCFA were assessed. The results are
presented in Table 1. Melittin exhibited antibacterial activity
on all the strains tested with MICs ranging between 5 and 35
Wg/ml. MCF also exhibits activity against three of the organ-
isms tested, but the MICs are higher and it is V5^7 times less
active as compared to melittin. MCFA, on the other hand,
has MICs comparable to that of melittin. Thus a minor re-
arrangement in the sequence of MCF which results in in-
creased 6WHs , leads to considerable increase in its antimi-
crobial activity. A majority of antimicrobial peptides are
known to exert their activity by permeabilizing their mem-
branes, hence the ability of the three peptides to permeabilize
the cytoplasmic membrane of E. coli was examined by assess-
ing the in£ux of ONPG into E. coli in the presence and ab-
sence of the peptides. The data shown in Fig. 2 indicate that
all the three peptides indeed open up additional pathways for
ONPG uptake besides the normal lac permease route. The
relative abilities of these peptides to permeabilize the cytoplas-
mic membrane parallel their MICs against E. coli.
The hemolytic activities of the three peptides are compared
in Fig. 3a. Melittin exhibits 100% lytic activity at 1 Wg/ml
concentration. MCF shows V50% lysis at 100 Wg/ml reaching
a value of 100% beyond 300 Wg/ml. Thus MCF is 300 times
less active than melittin. MCFA is comparatively more hemo-
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Fig. 1. Sequnces of melittin, MCF and MCFA. Helical wheel projections of MCF and MCFA are also shown. Polar residues are underlined.
Table 1
Antimicrobial activity of melittin and its analogs
Peptide MIC (Wg/ml) against
E. coli W 160-37 S. aureus 8530 B. subtilis P. putida NCIM 2102
Melittin 5^10 10^15 2^4 25^35
MCF 35^45 25^35 15^25 s 200
MCFA 10^15 5^10 2^4 50^60
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lytic than MCF showing 100% lysis at 100 Wg/ml, but as
compared to melittin it is still 100 times less active. Melittin
exerts its hemolytic e¡ect by colloid-osmotic mechanism [21].
In order to determine whether MCF and MCFA also follow a
similar mechanism, lysis of red blood cells by the three pep-
tides was assessed in the presence of osmoprotectants sucrose,
maltose, ra⁄nose and PEGs 600 and 1000. Virtually the ¢rst
three molecules provided no protection to lysis (results not
shown). But, in the presence of PEG 600 and PEG 1000 no
hemolytic activity was observed. Thus, osmoprotectants of
s 20 Aî gave protection to hemolysis caused by all the pep-
tides, suggesting that all the three peptides indeed followed
colloid-osmotic mechanism and the size of the lesions made
by them is V20 Aî .
Amphiphilic peptides like melittin show a tendency to ag-
gregate in aqueous solution as a function of concentration
[22]. Hence the aggregation properties of MCF and MCFA
were compared with that of melittin. The data shown in Fig.
3b indicate that while melittin aggregates between 10 WM and
50 WM concentrations, MCF has the ability to aggregate be-
yond 100 WM. MCFA exhibits concentration dependent ag-
gregation beyond 50 WM. The scatter values also indicate that
the aggregates of MCFA may indeed be bigger than melittin
aggregates. The aggregation properties of the peptides corre-
late well with their ability to cause hemolysis.
Melittin adopts a tetrameric helical structure in aqueous
medium at high ionic strength [23]. Hence the folding of me-
littin and its shorter analogs, MCF and MCFA, were inves-
tigated by both circular dichroism, as well as by £uorescence
spectroscopy, as all the three peptides contain a single Trp
residue each. The results are summarized in Table 2. A steady
decrease in a222 value, in the case of melittin, as a function of
ionic strength is discernible. This indicates an increase in its K-
helical content. Such increases in K-helical contents are not
observed in the cases of MCF and MCFA, indicating the
inability of these peptides to fold at high salt concentrations.
Melittin also exhibits a pronounced salt induced blue shift,
from 351 to 339 nm, in its emission maximum (Vmax). Such
a blue shift has been attributed to the formation of tetrameric
aggregates. MCF and MCFA do not exhibit any such blue
shift, indicating again the absence of any salt induced folding
or aggregation in these short peptides, unlike melittin.
Alcohols are known to induce monomeric K-helical struc-
ture in melittin as opposed to increased ionic strength, which
favors tetramerization [24,25]. In order to investigate the be-
havior of MCF and MCFA in alcohols, CD spectra and £uo-
rescence emission spectra (Fig. 4a and b) of the three peptides
were recorded in the presence of various concentrations of
MeOH. While all the three peptides occur in unordered con-
formation in the absence of MeOH, addition of MeOH sta-
bilizes the K-helix in all the three peptides (Fig. 4a). The
results shown in Fig. 4b reveal blue shifts in the emission
maximum in the case of all the three peptides in methanol
rich phases. Thus while melittin can fold into K-helix confor-
mation both in the tetrameric form (at high ionic strength)
and in monomeric form (in methanol), the shorter analogs can
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Fig. 2. E¡ect of melittin (a), MCF (E) and MCFA (O) on the in-
£ux of ONPG into E. coli W 160.37. Peptide concentrations of 20
Wg/ml were used in the assay.
Fig. 3. (a) Hemolysis of rat erythrocytes as a function of peptide
concentrations (symbols used are same as in Fig. 2). (b) Light scat-
tering (90‡ angle) of aqueous solution of peptides. Peptides were in
10 mM HEPES bu¡er (pH 7.4).
Table 2
Salt induced folding of melittin and its analogs
[NaCl] (M) Melittin MCF MCFA
3a222 [fh] Vmax [vV] 3a222 [fh] Vmax [vV] 3a222 [fh] Vmax [vV]
0 4213 [0.08] 350 [0] 1389 [0] 350.4 [0] 2913 [0.03] 353.6 [0]
0.3 4716 [0.10] 349 [31] 3015 [0.04] 351.4 [+1.4] 3497 [0.05] 355 [+1.4]
0.6 5108 [0.11] 346 [34] 3584 [0.05] 352 [+2.0] 4404 [0.09] 356 [+2.4]
0.9 7184 [0.19] 341 [39] 3750 [0.06] 351 [+0.6] 4500 [0.09] 356 [+2.4]
1.2 8825 [0.24] 339 [311] 3879 [0.07] 351 [+0.6] 4589 [0.10] 356 [+2.4]
1.5 13245 [0.41] 338 [312] 4651 [0.10] 351 [+0.6] 4895 [0.11] 356 [+2.4]
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only exist in the monomeric K-helix conformation, but are
incapable of self associating to form higher aggregates at
high ionic strengths.
4. Discussion
Melittin is a 26-residue peptide with a predominantly hy-
drophobic N-terminal segment from 1^20 residues and a cat-
ionic tail of six residues between 21^26 [26]. The segment
between 1^20, although membrane active, does not possess
any lytic activity. Even the cationic segment 21^26 is inactive
[27,28]. However, melittin has an 11-residue segment between
12^22, which falls in ‘surface seeking’ region of the ‘hydro-
phobic moment’ plot [29]. Such segments play an important
role in the biological activities of several antimicrobial/lytic
peptides. Short synthetic peptide, encompassing ‘surface seek-
ing’ segments have been shown to exhibit antimicrobial and
hemolytic activities [6^8,11,30^32]. Thus, it was interesting to
see whether a synthetic peptide corresponding to C-terminal
12^26 segment of melittin, encompassing its most amphiphilic
region, also possesses biological activity. Hence MCF was
synthesized and its properties studied. MCF indeed possessed
both antimicrobial and hemolytic activities, albeit to a very
small extent compared to melittin. It is very well established
that cationicity, mean hydrophobicity (6Hs ) and hydro-
phobic moments (6WHs ) of a peptide are the determining
factors of biological activity of cytolytic peptides [33^37].
Small change in WH values has been demonstrated to modu-
late these activities of the peptide [37,38]. An examination of
the helical wheel diagram of MCF (Fig. 1) indicates that
although it happens to be most amphiphilic region of melittin
cationic residues 12 and 13 are in the hydrophobic face of the
helix. Hence it is possible to increase the amphiphilicity of the
peptide by transposing these residues to the hydrophilic face
of the helix. These residues were therefore replaced for proline
3 and alanine 4. As Pro residue is known to be a structure
breaker this was replaced at position 12 by Ala which is an K-
helix stabilizer. These changes increase the WH of 1^12 seg-
ment of the peptide considerably (0.42 to 0.75) without much
change in mean hydrophobicity. The antimicrobial activity of
MCFA is comparable to that of melittin, but its hemolytic
activity is less pronounced. Thus it is possible to design short
peptides with relatively selective antimicrobial activity, by ju-
diciously positioning the charged amino acids.
Antibacterial peptides, whose activities stem from their abil-
ity to interact with the membranes, are known to compromise
the permeability barriers of the bacterial membranes [15]. Me-
littin and its two short analogs also e¡ectively permeabilized
the cytoplasmic membrane of E. coli to ONPG, by opening
additional pathways for its in£ux in addition to the protein
transporter lac permease, indicating that the underlying mech-
anism of antimicrobial activity for all the three peptides is
likely to be the same.
Most cytolytic peptides are known to lyse the cells by for-
mation of discrete transmembrane pores, which allows small
molecules to move across the membrane [39]. However, large
molecules like proteins cannot move through these small
pores and because of this the cell interior becomes hyperos-
motic. This is counter balanced by a net in£ux of water, which
results in swelling of the cell and subsequent lysis. By includ-
ing osmoprotectants of appropriate size, which cannot pene-
trate the induced pores, it is possible to counter balance the
osmotic drag. By determining the size of the osmoticants that
is able to give protection to lysis it is possible to make a rough
estimate of the size of the pores induced by the peptide. In the
case of these three peptides hemolysis was virtually blocked by
PEGs 600 and 1000 and thus the probable size of the induced
pores was V20 Aî .
Despite the absence of qualitative di¡erences in the biolog-
ical activities of the three peptides studied here, quantitative
di¡erences are quite evident. The segment 1^7 in melittin is
very important in modulating the biophysical as well as bio-
logical properties of melittin, as 8^26-peptide is very weakly
lytic on model lipid membranes [28,40]. However, there are no
reports describing the antimicrobial and hemolytic activities
of short C-terminal fragments of melittin. The low antimicro-
bial and hemolytic activities of MCF could be attributed to
the absence of the N-terminal segment of melittin. MCFA, on
the other hand, has antimicrobial activity comparable to that
of melittin and hemolytic activity considerably more than that
of MCF. An examination of the helical wheel diagram of
MCF and MCFA reveals the presence of a larger hydropho-
bic face in MCFA. A larger hydrophobic face, in an amphi-
philic peptide, favors the formation of relatively stable trans-
membrane pores and consequently better biological activity.
Such peptides with large hydrophobic face have indeed been
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Fig. 4. (a) Circular dichroism (CD) spectra of peptides (melittin (a),
MCF (O) and MCFA (E)) in aqueous bu¡er (open symbols) and
methanol (darkened symbols). (b) Fluorescence emission maximum
(Vmax) as function of methanol content in water. All measurements
were made at 25‡C using 20 WM peptide.
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shown to possess strong hemolytic activity [41,42]. The pres-
ence of cationic residues on the hydrophobic face in MCF is
likely to destabilize transmembrane pores leading to poor bio-
logical activity.
In an attempt to correlate the biological activities with the
biophysical properties of the peptides, their structural prefer-
ences were investigated in aqueous solutions as well as meth-
anol. The association and folding properties of melittin are
known to be dependent on its N-terminal 1^11-segment and
particularly the polar residue at position 7 seems to play a
predominant role [21,43]. As both MCF and MCFA lack this
segment it was also interesting to study their folding and
aggregation behavior. All the three peptides are unordered
in dilute aqueous solution. The CD spectra of the three pep-
tides in methanol are characteristic of K-helical structure, with
double minima at 222 V and 208 V and cross over at V200 V,
indicating their intrinsic preference to acquire K-helical struc-
ture [44]. MCF exhibits very poor folding and aggregating
properties as a function of peptide concentration as well as
at high ionic strength, emphasizing again the importance of
the N-terminal segment of melittin for these attributes. How-
ever, MCFA’s large hydrophobic face would explain its ag-
gregation as a function of peptide concentration. The forma-
tion of these aggregates in MCF is likely to be due to non-
speci¢c aggregation, as opposed to speci¢c tetramer formation
in melittin. One would expect MCFA to form similar aggre-
gates at high salt concentrations also and the failure to detect
them remains unclear at this time.
Structure function studies on magainin and cecropins have
indicated that deletion of up to three amino acids from the N-
terminal end resulted in analogs with considerably reduced
antimicrobial activity [45]. Further reduction in length ap-
pears to result in complete loss of activity. In this study we
have shown that deletion of 11 residues from the N-terminal
end of melittin results in a 15-residue peptide (MCF), encom-
passing its most amphiphilic segment, that exhibits both anti-
microbial and hemolytic activities. An analog of this peptide,
in which two cationic residues are trans-positioned to the N-
terminal region from the C-terminal region that results in
increased WH, shows antimicrobial activity comparable to
that of melittin, but with marginal hemolytic activity. Thus
it is possible to rationally design short peptides with enhanced
antimicrobial activity from highly hemolytic peptides on the
basis of biophysical principles.
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